Skip to main content

Filter

2026-05-05

Cellis secures FENG (NCBR) funding for glioblastoma therapy

Cellis has been awarded funding under the European Funds for a Modern Economy (FENG 2021–2027),…
2026-03-10

NCBR Recognizes Cellis Team for Award-Winning Glioblastoma Research

Cellis has been recognized by the National Centre for Research and Development (NCBR) following the…
2026-01-29

Pfizer Research Prize 2026 for Macrophage-Based Glioblastoma Therapy

We are pleased to announce that Cellis’ Macrophage-Drug Conjugate (MDC) platform has been awarded the…
2025-11-20

Cellis CEO to Speak in Copenhagen at EU Cancer Mission 2025

On 4 December 2025, leaders in oncology will gather in Copenhagen for the EU Cancer…